ReviewCrohn's & colitis 3602025

Effect of glucagon-like peptide-1 receptor agonists on major adverse cardiovascular events in patients with inflammatory bowel disease.

Michael Saadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.